Arachidonic Acid Metabolism Controls Macrophage Alternative Activation Through Regulating Oxidative Phosphorylation in PPARγ Dependent Manner

Macrophage polarization is mainly steered by metabolic reprogramming in the tissue microenvironment, thus leading to distinct outcomes of various diseases. However, the role of lipid metabolism in the regulation of macrophage alternative activation is incompletely understood. Using human THP-1 and mouse bone marrow derived macrophage polarization models, we revealed a pivotal role for arachidonic acid metabolism in determining the phenotype of M2 macrophages. We demonstrated that macrophage M2 polarization was inhibited by arachidonic acid, but inversely facilitated by its derived metabolite prostaglandin E2 (PGE2). Furthermore, PPARγ bridges these two seemingly unrelated processes via modulating oxidative phosphorylation (OXPHOS). Through inhibiting PPARγ, PGE2 enhanced OXPHOS, resulting in the alternative activation of macrophages, which was counterweighted by the activation of PPARγ. This connection between PGE2 biosynthesis and macrophage M2 polarization also existed in human and mouse esophageal squamous cell carcinoma. Our results highlight the critical role of arachidonic acid and metabolic PGE2 as immune regulators in modulating tissue homeostasis and pathological process.

[1]  L. Jones,et al.  Exercise and immunometabolic regulation in cancer , 2020, Nature Metabolism.

[2]  Linna Peng,et al.  Single-cell transcriptomic analysis in a mouse model deciphers cell transition states in the multistep development of esophageal cancer , 2020, Nature Communications.

[3]  A. Iavarone,et al.  ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages , 2020, Nature Communications.

[4]  S. Koizumi,et al.  Prostaglandin E Receptor 4 Antagonist in Cancer Immunotherapy: Mechanisms of Action , 2020, Frontiers in Immunology.

[5]  X. Jia,et al.  CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis , 2020, Molecular Cancer.

[6]  P. Singh,et al.  Metabolic Regulation of Macrophage Polarization in Cancer. , 2019, Trends in cancer.

[7]  M. Horton,et al.  Targeting metabolism to regulate immune responses in autoimmunity and cancer , 2019, Nature Reviews Drug Discovery.

[8]  L. Galluzzi,et al.  Macrophages and Metabolism in the Tumor Microenvironment. , 2019, Cell metabolism.

[9]  B. Brüne,et al.  Strategies to Interfere with Tumor Metabolism through the Interplay of Innate and Adaptive Immunity , 2019, Cells.

[10]  R. Pierce,et al.  Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma , 2019, Cancer Immunology Research.

[11]  J. Ahmed,et al.  Expression analysis of cyclooxygenase-2 in patients suffering from esophageal squamous cell carcinoma , 2018, PloS one.

[12]  David S. Wishart,et al.  MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis , 2018, Nucleic Acids Res..

[13]  X. Jia,et al.  Tocopherols inhibit esophageal carcinogenesis through attenuating NF-κB activation and CXCR3-mediated inflammation , 2018, Oncogene.

[14]  S. Biswas,et al.  Metabolic regulation of macrophage phenotype and function , 2017, Immunological reviews.

[15]  L. Degraffenried,et al.  Effects of Obesity on the Regulation of Macrophage Population in the Prostate Tumor Microenvironment , 2017, Nutrition and cancer.

[16]  U. Taschler,et al.  Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling , 2017, Pharmacology & therapeutics.

[17]  D. Wallace,et al.  Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments. , 2017, Cell metabolism.

[18]  B. Dwarakanath,et al.  Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy , 2017, Front. Oncol..

[19]  G. Hotamışlıgil.  Inflammation, metaflammation and immunometabolic disorders , 2017, Nature.

[20]  T. Chao,et al.  PPARs modulate cardiac metabolism and mitochondrial function in diabetes , 2017, Journal of Biomedical Science.

[21]  A. Saghatelian,et al.  Gpr132 sensing of lactate mediates tumor–macrophage interplay to promote breast cancer metastasis , 2017, Proceedings of the National Academy of Sciences.

[22]  B. Brüne,et al.  Macrophage fatty acid oxidation and its roles in macrophage polarization and fatty acid-induced inflammation. , 2016, Biochimica et biophysica acta.

[23]  A. D. de Vos,et al.  Mitochondrial Dysfunction Prevents Repolarization of Inflammatory Macrophages. , 2016, Cell reports.

[24]  J. Rathmell,et al.  A guide to immunometabolism for immunologists , 2016, Nature Reviews Immunology.

[25]  A. Sjölander,et al.  The eicosanoids leukotriene D4 and prostaglandin E2 promote the tumorigenicity of colon cancer-initiating cells in a xenograft mouse model , 2016, BMC Cancer.

[26]  C. Reker-Smit,et al.  PGE2‐treated macrophages inhibit development of allergic lung inflammation in mice , 2016, Journal of leukocyte biology.

[27]  C. Thompson,et al.  The Emerging Hallmarks of Cancer Metabolism. , 2016, Cell metabolism.

[28]  David K. Finlay,et al.  Immunometabolism: Cellular Metabolism Turns Immune Regulator* , 2015, The Journal of Biological Chemistry.

[29]  K. Larsson,et al.  COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset , 2015, Proceedings of the National Academy of Sciences.

[30]  W. Zou,et al.  Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies , 2015, Cancer Immunology Research.

[31]  Jonathan R. Brestoff,et al.  Immune Regulation of Metabolic Homeostasis in Health and Disease , 2015, Cell.

[32]  Y. Li,et al.  Isoliquiritigenin, a flavonoid from licorice, blocks M2 macrophage polarization in colitis-associated tumorigenesis through downregulating PGE2 and IL-6. , 2014, Toxicology and applied pharmacology.

[33]  Maxim N. Artyomov,et al.  Cell-intrinsic lysosomal lipolysis is essential for macrophage alternative activation , 2014, Nature Immunology.

[34]  S. Dey,et al.  Peroxisome proliferator-activated receptor δ promotes colonic inflammation and tumor growth , 2014, Proceedings of the National Academy of Sciences.

[35]  W. Di,et al.  High MUC2 Expression in Ovarian Cancer Is Inversely Associated with the M1/M2 Ratio of Tumor-Associated Macrophages and Patient Survival Time , 2013, PloS one.

[36]  E. Pearce,et al.  Metabolic pathways in immune cell activation and quiescence. , 2013, Immunity.

[37]  A. Chawla,et al.  The immune system as a sensor of the metabolic state. , 2013, Immunity.

[38]  Alberto Mantovani,et al.  Orchestration of metabolism by macrophages. , 2012, Cell metabolism.

[39]  A. Chawla,et al.  Alternative macrophage activation and metabolism. , 2011, Annual review of pathology.

[40]  Frank Brombacher,et al.  Macrophage-specific PPARγ controls alternative activation and improves insulin resistance , 2007, Nature.

[41]  D. Greaves,et al.  Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. , 2006, Cell metabolism.

[42]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Hull,et al.  Activity of the non-steroidal anti-inflammatory drug indomethacin against colorectal cancer. , 2003, Cancer treatment reviews.

[44]  Chantal Couture,et al.  Mechanisms of action , 1994, Schizophrenia Research.

[45]  Mustafa Saad,et al.  Implications for Therapy , 2016 .

[46]  P. Carmeliet,et al.  Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population. , 2014, Cancer research.